Our data confirm LRP4 as a novel auto-antigen in MG patients; moreover, our results indicate that autoantibodies against LRP4 may coexist with anti-AChR and anti-MuSK abs suggesting new perspectives in MG-patients management. The gene discussed is LRP4; the disease is myasthenia gravis.